Smart Pill Technologies Market Analysis

Smart Pill Technologies Market: Segmentation

The Smart pill technologies market is classified on the basis of application, disease indication and geography.

Smart Pill Technologies Market: Overview

The smart pill technologies has recently entered the market and is rapidly penetrating the developed as well as developing countries. The growing demand and escalating adoption rate for monitoring and treating diseases by newly advanced technologies has given an impetus to the global smart pill technologies market. In the last few years the market has seen high percentage of acceptance towards usage due to non-invasiveness, better patient accessibility and thorough monitoring. Capsule endoscopy accounted for the highest revenue in 2014. The first capsule endoscope model, which is now regarded as a first-line tool for the detection of abnormalities of the small bowel, was the PillCam SB. It was approved in Japan in April 2007. GI monitoring application segment is expected to register fastest growth in the forecast period, amongst all other segments. In the coming years, global smart pill technologies market will witness significant developments in innovation of a wide range of new products that will require novel marketing approaches. The smart pill technologies market is currently underpenetrated and in its nascent stage of development. Although the maximum revenues are generated by the developed countries, it is also observed that CAGR in the developing countries are high. The reason for the growth in the CAGR can be attributed to the increasing awareness in the latest innovative testing methods and the continuously improving economic conditions.

Smart Pill Technologies Market: Region-wise Outlook

On the basis of geography, Global Smart pill technologies market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America and Europe collectively accounted for the largest market share in the overall smart pills technology market, in 2014. North America accounted for about half the share of market revenue in 2014. The growth in this region is primarily attributed to the early adoption of novel technologies, a large patient population, high disposable incomes and the fresh marketing and commercializing of smart pill products. Asia Pacific is expected to grow at a remarkable CAGR for smart pills technologies market due to increasing healthcare awareness.

Smart Pill Technologies Market: Key Players

Key players in the global Nucleic Acid Testing market include CapsoVision, Inc., Given Imaging, Inc., Medimetrics S.A. de C.V., Olympus Corporation, and Bio-Images Research Limited, IntroMedic Inc., Chongqing Jinshan Science & Technology Group Co. Ltd., Proteus Digital Health Inc., Novartis AG, and Philips Healthcare.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.